VRTX:NGS-Vertex Pharmaceuticals Incorporated (USD)

EQUITY | Biotechnology | Nasdaq Global Select

Last Closing

USD 509.04

Change

-2.70 (-0.53)%

Market Cap

USD 21.38B

Volume

0.84M

Analyst Target

USD 306.43
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-25 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
REGN Regeneron Pharmaceuticals Inc

+1.53 (+0.24%)

USD 76.39B
ARGX argenx NV ADR

-4.32 (-0.73%)

USD 37.97B
ALNY Alnylam Pharmaceuticals Inc

-2.56 (-0.94%)

USD 31.94B
ONC BeiGene, Ltd.

+4.79 (+1.82%)

USD 28.70B
RPRX Royalty Pharma Plc

-0.28 (-0.88%)

USD 19.31B
SMMT Summit Therapeutics PLC

-0.28 (-1.36%)

USD 14.57B
UTHR United Therapeutics Corporatio..

-1.05 (-0.34%)

USD 14.37B
INCY Incyte Corporation

-0.08 (-0.13%)

USD 14.22B
MRNA Moderna Inc

-1.00 (-3.11%)

USD 13.74B
INSM Insmed Inc

+0.30 (+0.39%)

USD 13.70B

ETFs Containing VRTX

DCCHAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

+0.35 (+-2.47%)

USD 0.08B
DCUSAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

+0.16 (+-2.47%)

N/A
DCEUAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

N/A
DCGBAS:SW UBS (Irl) Fund Solutions .. 90.84 % 0.00 %

N/A

N/A
BBH VanEck Biotech ETF 12.83 % 0.35 %

-1.34 (-2.47%)

USD 0.40B
IBB iShares Biotechnology ETF 9.31 % 0.47 %

-1.29 (-2.47%)

USD 6.00B
CURG:LSE VanEck Genomics and Healt.. 8.43 % 0.00 %

-0.29 (-2.47%)

USD 5.16M
MSGR 8.22 % 0.00 %

N/A

N/A
CURE:XETRA VanEck Genomics and Healt.. 7.99 % 0.00 %

-0.41 (-2.47%)

N/A
BTEC:SW iShares Nasdaq US Biotech.. 7.95 % 0.00 %

+0.05 (+-2.47%)

N/A
BIS ProShares UltraShort Nasd.. 7.21 % 0.95 %

+0.31 (+-2.47%)

USD 3.28M
BIB ProShares Ultra Nasdaq Bi.. 6.83 % 0.95 %

-0.88 (-2.47%)

USD 0.06B
UBIO 6.52 % 0.95 %

N/A

N/A
LIFE-B:CA Evolve Global Healthcare .. 5.49 % 0.00 %

+0.08 (+-2.47%)

N/A
ZWHC:CA BMO Covered Call Health C.. 5.16 % 0.00 %

-0.22 (-2.47%)

N/A
LIFE-U:CA Evolve Global Healthcare .. 5.00 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.94 % 0.00 %

-0.31 (-2.47%)

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.91 % 0.00 %

-0.49 (-2.47%)

N/A
BRIF NEOS ETF Trust 4.89 % 0.00 %

-0.29 (-2.47%)

N/A
XNNS:LSE Xtrackers MSCI Innovation.. 4.83 % 0.00 %

-0.83 (-2.47%)

N/A
XNNV:LSE Xtrackers MSCI Innovation.. 4.83 % 0.00 %

-1.12 (-2.47%)

N/A
XNNV:XETRA Xtrackers MSCI Innovation.. 4.76 % 0.00 %

-1.16 (-2.47%)

N/A
HEAL:CA 3.39 % 0.00 %

N/A

N/A
RILA Spinnaker ETF Series 3.30 % 0.00 %

-0.24 (-2.47%)

N/A
CDNA:CA CI Bio-Revolution Index E.. 2.75 % 0.00 %

-0.26 (-2.47%)

CAD 6.70M
BIOT:SW L&G Pharma Breakthrough U.. 2.68 % 0.00 %

-0.10 (-2.47%)

N/A
CURE:AU ETFS S&P Biotech ETF 2.52 % 0.00 %

+0.30 (+-2.47%)

USD 0.04B
UPWD 2.43 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.24 % 0.00 %

+0.03 (+-2.47%)

N/A
DOCG:LSE L&G Healthcare Breakthrou.. 2.20 % 0.00 %

-14.05 (-2.47%)

USD 0.06B
DOCT:LSE L&G Healthcare Breakthrou.. 2.20 % 0.00 %

N/A

USD 0.06B
POWA Invesco Bloomberg Pricing.. 2.11 % 0.00 %

-1.12 (-2.47%)

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.10 % 0.00 %

-0.06 (-2.47%)

N/A
CAPG:CA Capital Group Global Equi.. 1.94 % 0.00 %

-0.50 (-2.47%)

CAD 0.05B
XLVE:CA 1.93 % 0.00 %

N/A

N/A
WBIO:LSE WisdomTree BioRevolution .. 1.93 % 0.00 %

-17.80 (-2.47%)

USD 4.04M
ESMV iShares ESG MSCI USA Min .. 1.50 % 0.00 %

-0.26 (-2.47%)

USD 8.61M
FLXU:SW Franklin U.S. Equity UCIT.. 1.17 % 0.00 %

-1.16 (-2.47%)

N/A
THNZ:XETRA 1.03 % 0.00 %

N/A

N/A
DEF 0.00 % 0.59 %

N/A

N/A
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

-1.86 (-2.47%)

N/A
LABD Direxion Daily S&P Biotec.. 0.00 % 1.00 %

+0.34 (+-2.47%)

USD 0.05B
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

-2.91 (-2.47%)

USD 0.66B
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

-0.70 (-2.47%)

N/A
SDG iShares MSCI Global Impac.. 0.00 % 0.49 %

-0.82 (-2.47%)

USD 0.19B
HTEC Robo Global® Healthcare .. 0.00 % 0.00 %

-0.41 (-2.47%)

USD 0.05B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.05 (-2.47%)

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.04 (-2.47%)

N/A
BIGT:LSE L&G Pharma Breakthrough U.. 0.00 % 0.00 %

-6.10 (-2.47%)

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.04 (-2.47%)

N/A
VLQ:CA 0.00 % 0.40 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

-1.13 (-2.47%)

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

+0.14 (+-2.47%)

N/A
ZPW:CA BMO US Put Write ETF 0.00 % 0.71 %

-0.28 (-2.47%)

CAD 0.07B
HWWA:LSE HSBC Multi Factor Worldwi.. 0.00 % 0.00 %

-0.41 (-2.47%)

N/A
SMRG:LSE 0.00 % 0.00 %

N/A

N/A
SMRU:LSE 0.00 % 0.00 %

N/A

N/A
HWWD:LSE HSBC Multi Factor Worldwi.. 0.00 % 0.00 %

-0.59 (-2.47%)

N/A
VMOM:LSE 0.00 % 0.00 %

N/A

N/A
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

+1.20 (+-2.47%)

USD 0.10B
XT2D:LSE db x-trackers S&P 500 2x .. 0.00 % 0.00 %

+0.01 (+-2.47%)

USD 0.05B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

-0.07 (-2.47%)

USD 0.52B
ETLI:F Legal & General UCITS ETF.. 0.00 % 0.00 %

+0.01 (+-2.47%)

N/A
FLXU:F Franklin LibertyShares IC.. 0.00 % 0.00 %

-1.33 (-2.47%)

N/A
SM8T:F 0.00 % 0.00 %

N/A

N/A
XAIN:F Xtrackers - MSCI Indonesi.. 0.00 % 0.00 %

-0.11 (-2.47%)

USD 0.04B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

-0.06 (-2.47%)

USD 0.52B
DBPK:XETRA db x-trackers S&P 500 2x .. 0.00 % 0.00 %

+0.01 (+-2.47%)

USD 0.05B
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

-0.03 (-2.47%)

N/A
FBT:LSE First Trust Global Funds .. 0.00 % 0.00 %

-21.20 (-2.47%)

USD 8.62M
FBTU:LSE First Trust Global Funds .. 0.00 % 0.00 %

-0.26 (-2.47%)

USD 8.52M
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

-0.07 (-2.47%)

CAD 0.08B
QQEQ:CA Invesco NASDAQ 100 Equal .. 0.00 % 0.00 %

N/A

CAD 0.01B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

-0.20 (-2.47%)

USD 0.04B
FFND The Future Fund Active ET.. 0.00 % 0.00 %

-0.46 (-2.47%)

USD 0.06B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 26.41% 88% B+ 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.41% 88% B+ 92% A
Trailing 12 Months  
Capital Gain 21.65% 83% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.65% 83% B 78% C+
Trailing 5 Years  
Capital Gain 126.75% 87% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 126.75% 87% B+ 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 17.18% 65% D 71% C-
Dividend Return 17.18% 65% D 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.52% 91% A- 68% D+
Risk Adjusted Return 64.79% 97% N/A 85% B
Market Capitalization 21.38B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Biotechnology) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 32.57 22% 29%
Price/Book Ratio 7.51 18% 17%
Price / Cash Flow Ratio -250.11 99% 99%
Price/Free Cash Flow Ratio 244.37 1% 1%
Management Effectiveness  
Return on Equity -3.15% 93% 55%
Return on Invested Capital -5.98% 77% 44%
Return on Assets 12.68% 98% 97%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector